Eliem Therapeutics Stock (NASDAQ:ELYM), Quotes and News Summary

Q: What sector and industry does Eliem Therapeutics (ELYM) operate in?

Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Eliem Therapeutics Stock (NASDAQ: ELYM) stock price, news, charts, stock research, profile.

Open	$3.950
Close	$3.750
Volume / Avg.	86.068K / 683.863K
Day Range	3.710 - 4.160
52 Wk Range	2.340 - 5.190
Market Cap	$107.551M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.15%
Days to Cover	1.73

Recent News

Nasdaq Jumps 250 Points; Crude Oil Down 1%

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26.

Avi Kapoor

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Avi Kapoor

Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal

Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. Strategic alternatives explored. $120 million private placement. Acquisition expected mid-2024.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Eliem Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Eliem Therapeutics (ELYM) stock?

You can purchase shares of Eliem Therapeutics (NASDAQ: ELYM) through any online brokerage.

View our list of the best stock brokerages.

Who are Eliem Therapeutics's (ELYM) competitors?

Other companies in Eliem Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), FibroGen (NASDAQ:FGEN) and Barinthus Biotherapeutics (NASDAQ:BRNS).

What is the target price for Eliem Therapeutics (ELYM) stock?

The latest price target for Eliem Therapeutics (NASDAQ: ELYM) was reported by HC Wainwright & Co. on Wednesday, March 8, 2023. The analyst firm set a price target for 6.00 expecting ELYM to rise to within 12 months (a possible 54.64% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Eliem Therapeutics (ELYM)?

The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $3.88 last updated April 22, 2024 at 7:44 AM EDT.

Does Eliem Therapeutics (ELYM) pay a dividend?

There are no upcoming dividends for Eliem Therapeutics.

When is Eliem Therapeutics (NASDAQ:ELYM) reporting earnings?

Eliem Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Eliem Therapeutics (ELYM) going to split?

There is no upcoming split for Eliem Therapeutics.

What sector and industry does Eliem Therapeutics (ELYM) operate in?

Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-